{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:54:08Z","timestamp":1785466448889,"version":"3.56.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.intimp.2021.108306","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T13:22:31Z","timestamp":1641475351000},"page":"108306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1\/AMPK signaling"],"prefix":"10.1016","volume":"104","author":[{"given":"Liping","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiyun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.intimp.2021.108306_b0005","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.intimp.2021.108306_b0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nature Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108306_b0015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2021.108306_b0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu. Rev. Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108306_b0025","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/hep.31436","article-title":"iRhom2 promotes hepatic steatosis by activating MAP3K7-dependent pathway","volume":"73","author":"Xu","year":"2021","journal-title":"Hepatology"},{"issue":"7121","key":"10.1016\/j.intimp.2021.108306_b0030","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.108306_b0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108306_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.intimp.2021.108306_b0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1514009","article-title":"Mechanisms, pathophysiology, and management of obesity","volume":"376","author":"Heymsfield","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.108306_b0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108306_b0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","article-title":"Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease","volume":"66","author":"Rotman","year":"2017","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.intimp.2021.108306_b0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.it.2013.03.007","article-title":"Cell type-specific function of TAK1 in innate immune signaling","volume":"34","author":"Ajibade","year":"2013","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2021.108306_b0065","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/iub.1078","article-title":"TAK1, more than just innate immunity","volume":"64","author":"Dai","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.intimp.2021.108306_b0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.freeradbiomed.2020.04.009","article-title":"Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1","volume":"153","author":"Wu","year":"2020","journal-title":"Free Radical Biol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2021.108306_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-52768-7","article-title":"Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling","volume":"7","author":"Wang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2021.108306_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101575","article-title":"Activation of the AMP-related kinase (AMPK) induces renal vasodilatation and downregulates Nox-derived reactive oxygen species (ROS) generation","volume":"34","author":"Rodr\u00edguez","year":"2020","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108306_b0085","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of nonalcoholic fatty liver disease: role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol.-Endocrinol. Metabol."},{"issue":"8","key":"10.1016\/j.intimp.2021.108306_b0090","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3390\/ijms19082412","article-title":"Is TAK1 a direct upstream kinase of AMPK?","volume":"19","author":"Neumann","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2021.108306_b0095","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/emboj.2009.8","article-title":"TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells","volume":"28","author":"Herrero-Mart\u00edn","year":"2009","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.intimp.2021.108306_b0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/ijms17020186","article-title":"Liensinine-and neferine-induced cardiotoxicity in primary neonatal rat cardiomyocytes and human-induced pluripotent stem cell-derived cardiomyocytes","volume":"17","author":"Yu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2021.108306_b0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/abbs\/gmz041","article-title":"Liensinine induces gallbladder cancer apoptosis and G2\/M arrest by inhibiting ZFX-induced PI3K\/AKT pathway","volume":"51","author":"Shen","year":"2019","journal-title":"Acta biochimica et biophysica Sinica"},{"key":"10.1016\/j.intimp.2021.108306_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104846","article-title":"Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission","volume":"157","author":"Liang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2021.108306_b0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bmc.2004.10.020","article-title":"Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nucifera, and structure\u2013activity correlations with related alkaloids","volume":"13","author":"Kashiwada","year":"2005","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2021.108306_b0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/app11010386","article-title":"Liensinine Prevents Vascular Inflammation by Attenuating Inflammatory Mediators and Modulating VSMC Function","volume":"11","author":"Jun","year":"2021","journal-title":"Appl. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2021.108306_b0125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s13765-015-0122-y","article-title":"Protective effect of liensinine on periodontitis through its antioxidant effect in mice","volume":"58","author":"Pang","year":"2015","journal-title":"J. Korean Soc. Appl. Biol. Chem."},{"key":"10.1016\/j.intimp.2021.108306_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101645","article-title":"Nrf2 mitigates prolonged PM2. 5 exposure-triggered liver inflammation by positively regulating SIKE activity: Protection by Juglanin","volume":"36","author":"Ge","year":"2020","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108306_b0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ptr.5541","article-title":"Gastrodin ameliorates oxidative stress and proinflammatory response in nonalcoholic fatty liver disease through the AMPK\/Nrf2 pathway","volume":"30","author":"Qu","year":"2016","journal-title":"Phytotherapy Res."},{"key":"10.1016\/j.intimp.2021.108306_b0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmet.2020.01.008","article-title":"Functional loss of inactive rhomboid-like protein 2 mitigates obesity by suppressing pro-inflammatory macrophage activation-triggered adipose inflammation","volume":"34","author":"Xu","year":"2020","journal-title":"Mol. Metabolism"},{"issue":"1","key":"10.1016\/j.intimp.2021.108306_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-27615-7","article-title":"Liver X receptors regulate hepatic F4\/80+ CD11b+ Kupffer cells\/macrophages and innate immune responses in mice","volume":"8","author":"Endo-Umeda","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2021.108306_b0150","first-page":"100","article-title":"Macrophages in nonalcoholic steatohepatitis: friend or foe?","volume":"6","author":"Grunhut","year":"2018","journal-title":"Eur. Med. J. Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2021.108306_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007929","article-title":"IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis","volume":"4","author":"Mas","year":"2009","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.intimp.2021.108306_b0160","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/15548627.2015.1056970","article-title":"A novel autophagy\/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission","volume":"11","author":"Zhou","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.intimp.2021.108306_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101626","article-title":"Metformin alleviates lead-induced mitochondrial fragmentation via AMPK\/Nrf2 activation in SH-SY5Y cells","volume":"36","author":"Yang","year":"2020","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.intimp.2021.108306_b0170","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1002\/jcp.30121","article-title":"SeP is elevated in NAFLD and participates in NAFLD pathogenesis through AMPK\/ACC pathway","volume":"236","author":"Chen","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"572","key":"10.1016\/j.intimp.2021.108306_b0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz2841","article-title":"Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome","volume":"12","author":"Rom","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.intimp.2021.108306_b0180","first-page":"631","article-title":"Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"16","author":"Nakamuta","year":"2005","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2021.108306_b0185","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radical Biol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2021.108306_b0190","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2021.108306_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","author":"Masarone","year":"2018","journal-title":"Oxidative Med. Cell. Longevity"},{"issue":"4","key":"10.1016\/j.intimp.2021.108306_b0200","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1572-0241.2005.41500.x","article-title":"Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease","volume":"100","author":"Yesilova","year":"2005","journal-title":"Am. J. Gastroenterol."},{"issue":"36","key":"10.1016\/j.intimp.2021.108306_b0205","doi-asserted-by":"crossref","first-page":"13079","DOI":"10.3748\/wjg.v20.i36.13079","article-title":"Role of Nrf2 in chronic liver disease","volume":"20","author":"Tang","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"6","key":"10.1016\/j.intimp.2021.108306_b0210","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.18632\/aging.102906","article-title":"Nrf2 deficiency aggravates PM2. 5-induced cardiomyopathy by enhancing oxidative stress, fibrosis and inflammation via RIPK3-regulated mitochondrial disorder","volume":"12","author":"Ge","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.intimp.2021.108306_b0215","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.taap.2010.03.016","article-title":"Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine-and choline-deficient diet","volume":"245","author":"Zhang","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2021.108306_b0220","article-title":"Keap1-knockdown decreases fasting-induced fatty liver via altered lipid metabolism and decreased fatty acid mobilization from adipose tissue","volume":"8","author":"Xu","year":"2013","journal-title":"PloS One"},{"issue":"25","key":"10.1016\/j.intimp.2021.108306_b0225","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.7150\/jca.32691","article-title":"Liensinine inhibited gastric cancer cell growth through ROS generation and the PI3K\/AKT pathway","volume":"10","author":"Yang","year":"2019","journal-title":"J. Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2021.108306_b0230","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1039\/C8FO01137K","article-title":"Liensinine perchlorate inhibits colorectal cancer tumorigenesis by inducing mitochondrial dysfunction and apoptosis","volume":"9","author":"Wang","year":"2018","journal-title":"Food Funct."},{"issue":"3","key":"10.1016\/j.intimp.2021.108306_b0235","first-page":"343","article-title":"Protective effect of Liensinine on lipopolysaccharide (LPS)-induced acute lung injury in mice","volume":"26","author":"Chen","year":"2018","journal-title":"Acta Laboratorium Animalis Scientia Sinica"},{"key":"10.1016\/j.intimp.2021.108306_b0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.fct.2013.08.036","article-title":"Resveratrol modulates autophagy and NF-\u03baB activity in a murine model for treating non-alcoholic fatty liver disease","volume":"63","author":"Li","year":"2014","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108306_b0245","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.intimp.2010.03.010","article-title":"Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1\/IKK\/NF-\u03baB and JNK\/p38 MAPK pathways","volume":"10","author":"Zeng","year":"2010","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2021.108306_b0250","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1172\/JCI74068","article-title":"TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis","volume":"124","author":"Inokuchi-Shimizu","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.intimp.2021.108306_b0255","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1074\/jbc.M608867200","article-title":"TAK1-dependent signaling requires functional interaction with TAB2\/TAB3","volume":"282","author":"Besse","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2021.108306_b0260","article-title":"Hepatic Regulator of G protein Signaling 5 Ameliorates NAFLD by Suppressing TAK1-JNK\/p38 Signaling","author":"Wang","year":"2020","journal-title":"Hepatology (Baltimore Md.)"},{"issue":"6","key":"10.1016\/j.intimp.2021.108306_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157246","article-title":"Macrophage activation in pediatric nonalcoholic fatty liver disease (NAFLD) correlates with hepatic progenitor cell response via Wnt3a pathway","volume":"11","author":"Carpino","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2021.108306_b0270","first-page":"2668","article-title":"Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice","volume":"11","author":"Luo","year":"2019","journal-title":"Am. J. Translat. Res."},{"issue":"1","key":"10.1016\/j.intimp.2021.108306_b0275","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm.4453","article-title":"The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2021.108306_b0280","first-page":"23","article-title":"Protective effect of liensinine on focal cerebral ischemia-reperfusion injury in rats","volume":"23","author":"Wangui","year":"2007","journal-title":"Pharmacol. Clin. Chin. Materia Med."},{"issue":"9","key":"10.1016\/j.intimp.2021.108306_b0285","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.freeradbiomed.2012.01.025","article-title":"Regulation of NAD (P) H oxidases by AMPK in cardiovascular systems","volume":"52","author":"Song","year":"2012","journal-title":"Free Radical Biol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2021.108306_b0290","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bbrc.2004.09.177","article-title":"AMPK inhibits fatty acid-induced increases in NF-\u03baB transactivation in cultured human umbilical vein endothelial cells","volume":"324","author":"Cacicedo","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2021.108306_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0612-z","article-title":"Activation of TGF-\u03b2-activated kinase 1 (TAK1) restricts Salmonella Typhimurium growth by inducing AMPK activation and autophagy","volume":"9","author":"Liu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.intimp.2021.108306_b0300","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00109-016-1434-z","article-title":"A retinoic acid receptor \u03b22 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease","volume":"94","author":"Trasino","year":"2016","journal-title":"J. Mol. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921009425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921009425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:35:26Z","timestamp":1761586526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921009425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":60,"alternative-id":["S1567576921009425"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108306","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1\/AMPK signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108306"}}